Lactational mastitis
Second line
Lactational mastitis with penicillin intolerance or suspected MRSA. Per ABM Protocol #36 2022 and SEGO 2023, second-line 300-450 mg 4 times daily for 10-14 days. Particularly indicated for community-acquired MRSA (CA-MRSA) – usually clindamycin-susceptible, unlike hospital MRSA.